|
pubmed:abstractText |
Pacemaker implantation following tricuspid valve surgery remains challenging, but recent developments in lead technology have significantly improved the options for ventricular pacing. In the presence of significant tricuspid regurgitation, steroid-eluting active-fixation leads should be used routinely, and in patients with a tricuspid prosthesis, the use of a dedicated cardiac venous pacing system is likely to be the best option.
|
